Respiratory Distress Syndrome in Premature Infants
12
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.3%
1 terminated out of 12 trials
87.5%
+1.0% vs benchmark
17%
2 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome
Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?
High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.
Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates
Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates
Respiratory Pattern During Neurally Adjusted Ventilator Assist (NAVA) in Preterm Infants
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
Successful Extubation and Noninvasive Ventilation in Preterm ≤ 1500g Terms
Study of Respiratory Physiology During High Flow Nasal Cannula Treatment in Preterm Neonates.